Skip to main content

Echo Therapeutics, Inc. (ECTE)

Sep 8, 2021 - ECTE was delisted (reason: registration revoked by SEC)
0.0002 0.0000 (0.00%)
Sep 3, 2021 9:30 AM EDT - Market closed
Market Cap72,025
Revenue (ttm)n/a
Net Income (ttm)-12.50M
Shares Out12.00M
EPS (ttm)-1.10
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume0
Open0.0002
Previous Close0.0002
Day's Range0.0002 - 0.0002
52-Week Range0.0001 - 0.0700
Beta6.78
Analystsn/a
Price Target2.00 (+999,900.0%)
Est. Earnings Daten/a

About ECTE

Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a needle-free wireless continuous glucose monitoring system in a hospital setting in the European Union. The company has a licensing agreement with Ferndale Pharma Group, Inc. to develop, manufacture, distribute, and market devices for skin preparation prior to the application of topical anesthetics or analgesics...

IndustryHealth Care Equipment & Supplies
IPO DateNov 10, 1997
Employees19
Stock ExchangeOTCMKTS
Ticker SymbolECTE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.